Amit Bhalla is a Director at Citi Investment Research & Analysis. He joined the firm in June 2006 covering the life sciences tools and medical technology industries. Before joining the firm, Mr. Bhalla worked for Morgan Stanley as a Vice President for five years covering the medical technology and specialty pharmaceuticals sectors. Before that, he worked at Johnson & Johnson’s Ortho-McNeil unit, rotating through several departments including research and development, quality control and manufacturing. Mr. Bhalla holds a B.S. in biology from Cornell University and an MBA from Carnegie Mellon University’s Tepper School of Business.
Higher-Efficiency Plays in Research and Diagnostics Despite Bearish Sentiments
August 01, 2012
Extended Tailwinds For Life Sciences & Diagnostic Tools - Amit Bhalla - Citi Investment Research & Analysis
June 13, 2011
Selectivity Is Key Among Headwinds In Medical Devices - Amit Bhalla - Citi Investment Research & Analysis
January 24, 2011